Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/2CL stock hub

FRA/2CL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2CLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.2B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/2CL

In the news

Latest news · FRA/2CL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-142.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2CL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

USD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	839
Employees Change	109%
Employees Change Percent	14.93
Enterprise value	EUR 12.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 11.2B
Price	EUR 59
Price currency	EUR
Rev Per Employee	600,952.89x
Sic	2836
Symbol	fra/2CL
Website	https://bridgebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.58%
EV Earnings	-20.03x
EV/FCF	-32.48x
EV/Sales	25.44x
FCF yield	-3.44%
P/B ratio	-5.7x
P/S ratio	22.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-86.94%
EBITDA Margin	-86.02%
Gross margin	95.13%
Gross Profit	EUR 478.5M
Gross Profit Growth	354.09%
Gross Profit Growth Q	61.92%
Gross Profit Growth3 Y	94.44%
Gross Profit Growth5 Y	129.26%
Net Income	EUR -625.8M
Pretax Margin	-125.78%
Profit Margin	-124.41%
Profit Per Employee	EUR -747,673
ROA	-27.98
Roa5y	-44.94
ROCE	-90.91
ROIC	-142.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	84.68%
Cagr3y	68.15%
Cagr5y	7.55%
Revenue Growth	355.17x
Revenue Growth Q	66.78x
Revenue Growth3 Y	95.36x
Revenue Growth5 Y	131.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.51
Assets	EUR 1.2B
Cash	EUR 815.4M
Current Assets	EUR 1.1B
Current Liabilities	EUR 692.3M
Debt	EUR 2.2B
Debt FCF	EUR -5.6
Equity	EUR -2B
Interest Coverage	-2.67
Liabilities	EUR 3.2B
Long Term Assets	EUR 136.5M
Long Term Liabilities	EUR 2.5B
Net Cash	EUR -1.3B
Net Cash By Market Cap	EUR -12.01
Tangible Book Value	EUR -2B
Tangible Book Value Per Share	EUR -10.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Inventory Turnover	1.53
Net Working Capital	EUR 31.8M
Quick ratio	1.4
Working Capital	EUR 368.5M
Working Capital Turnover	EUR 1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	84.61%
200-day SMA	54.91
3Y total return	375.62%
50-day SMA	60.49
50-day SMA vs 200-day SMA	50over200
5Y total return	43.9%
All Time High	72.8
All Time High Change	-18.96%
All Time High Date	2026-02-12
All Time Low	4.72
All Time Low Change	1,148.94%
All Time Low Date	2022-05-12
ATR	2.08
Ch YTD	-7.35
High	59
High52	72.8
High52 Date	2026-02-12
High52ch	-18.96%
Low	56.5
Low52	28.67
Low52 Date	2025-05-22
Low52ch	105.79%
Ma50ch	-2.46%
Price vs 200-day SMA	7.45%
RSI	45.25
RSI Monthly	64.83
RSI Weekly	52.02
Sharpe ratio	1.47x
Sortino ratio	2.25
Total Return	-1.99%
Tr YTD	-7.35
Tr1m	-2.77%
Tr1w	0.72%
Tr3m	10.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -437.3M
Operating margin	-86.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	162,820,107%
Net Borrowing	790,724,565
Shares Insiders	4.03%
Shares Institutions	83.58%
Shares Qo Q	0.64%
Shares Yo Y	1.99%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -507.8M
Average Volume	6.35x
Bv Per Share	-10.1
CAPEX	EUR -1M
Ch1m	-2.77
Ch1w	0.72
Ch1y	84.61
Ch3m	10.69
Ch3y	375.6
Ch5y	43.9
Ch6m	12.55
Change	1.67%
Change From Open	4.42
Close	58.03
Days Gap	-2.64
Depreciation Amortization	4,524,725.2
Dollar Volume	2,360
Earnings Date	2026-05-07
EBIT	EUR -437.3M
EBITDA	EUR -432.7M
EPS	EUR -3.25
F Score	2
FCF	EUR -386.1M
FCF EV Yield	-3.08x
Financing CF	736,213,676
Fiscal Year End	December
Founded	2,015
Income Tax	EUR 377,276
Investing CF	-56,918,297
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	59.17
Ma150ch	-0.29%
Ma20	62.22
Ma20ch	-5.18%
Net CF	294,254,075
Open	56.5
Position In Range	100
Ppne	18,796,773.7
Price Date	2026-05-08
Relative Volume	6.3x
Revenue	502,997,573x
SBC By Revenue	24.21x
Share Based Comp	121,755,043
Tax By Revenue	0.08x
Tr6m	12.55%
Volume	40

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/2CL pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2CL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/2CL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.6%

Share of float held by funds and institutions

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.0%

Negative means the company is buying back shares.

Technical

FRA/2CL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.2

Neutral momentum band

Price vs 200-day MA

+7.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2CL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2CL stock rating?

fra/2CL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2CL analysis?

The full report lives at /stocks/fra/2CL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2CL?

The latest report frames fra/2CL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2CL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.